home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Noncoding RNA May Drive Alzheimer's Disease

  July, 10 2008 8:32
your information resource in human molecular genetics
Scientists have found a molecular mechanism that may drive the progression of Alzheimer's disease. The mechanism, involving the enzyme Beta secretase 1 (BACE1), is described online in Nature Medicine, and could become a target for future therapeutic efforts. Upon exposure to amyloid-beta, the molecule that results from the activity of BACE1 and that accumulates in the amyloid plaques characteristic of Alzheimer's disease, expression of the noncoding RNA is enhanced, which increases the levels of BACE1 and generates additional amyloid-beta through a positive feedback loop.

Author contact:

Claes Wahlestedt (The Scripps Research Institute, Jupiter, FL, USA)
E-mail: clawah@scripps.edu

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.